PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11537374-1	1989	The gamma-irradiation of 0.1 M, O2-free, aqueous HCN was studied in the presence of ferrocyanide or ferricyanide in the concentration range 10(-3) - 10(-5) M.  This study was carried out in order to get an insight into the possible role that cyanocomplexes of iron may have played in promoting prebiotic syntheses via the free-radical oligomerization of HCN.	hexacyanoferrate II	84-96	metastasis associated lung adenocarcinoma transcript 1	Homo sapiens	49-52
2992572-5	1985	The rate of cytochrome c reduction is accelerated to 0.105 +/- 0.021 mu equiv min-1 (mg of protein)-1 when cytochrome c is pretreated with equimolar ferrocyanide.	hexacyanoferrate II	149-161	cytochrome c, somatic	Homo sapiens	12-24
2992389-0	1985	Characterization of cucumber ascorbate oxidase and its reaction with hexacyanoferrate (II).	hexacyanoferrate II	69-85	L-ascorbate oxidase	Cucumis sativus	29-46
2992389-4	1985	The reduction of AOase with a large excess of hexacyanoferrate(II) results in a selective reduction of the type-2 Cu, giving rise to an additional EPR-detectable species which is considered to be originated from partly reduced type-3 copper.	hexacyanoferrate II	46-62	L-ascorbate oxidase	Cucumis sativus	17-22
2992572-5	1985	The rate of cytochrome c reduction is accelerated to 0.105 +/- 0.021 mu equiv min-1 (mg of protein)-1 when cytochrome c is pretreated with equimolar ferrocyanide.	hexacyanoferrate II	149-161	CD59 molecule (CD59 blood group)	Homo sapiens	78-101
2992572-5	1985	The rate of cytochrome c reduction is accelerated to 0.105 +/- 0.021 mu equiv min-1 (mg of protein)-1 when cytochrome c is pretreated with equimolar ferrocyanide.	hexacyanoferrate II	149-161	cytochrome c, somatic	Homo sapiens	107-119
2992572-7	1985	The ferrocyanide-stimulated rate of cytochrome c reduction is further accelerated by the protonophore carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP), probably because FCCP dissipates the membrane potential generated by electron transfer.	hexacyanoferrate II	4-16	cytochrome c, somatic	Homo sapiens	36-48
6193086-7	1983	In this modified medium, Karnovsky"s cupric ferrocyanide becomes the sole precipitate at the enzymatic site and this provides fine localization of acetylcholinesterase activity.	hexacyanoferrate II	44-56	acetylcholinesterase (Cartwright blood group)	Homo sapiens	147-167
2983756-9	1985	The chromaffin-vesicle electron-transfer system reduces cytochrome c relatively slowly, but the rate is greatly accelerated by low concentrations of ferrocyanide.	hexacyanoferrate II	149-161	cytochrome c, somatic	Homo sapiens	56-68
6995116-0	1980	Production of glycolate by oxidation of the 1,2-dihydroxyethyl-thamin-diphosphate intermediate of transketolase with hexacyanoferrate(III) or H2O2.	hexacyanoferrate II	117-133	transketolase	Homo sapiens	98-111
6284722-0	1982	Characterization of electron donation to cytochrome c-555 in Chromatium vinosum from ferrocyanide, tetramethylphenylenediamine and reduced dimethylquinone.	hexacyanoferrate II	85-97	cytochrome c, somatic	Homo sapiens	41-53
6284722-3	1982	The dependences of the reduction of ferricytochrome c-555 in the reaction center-cytochrome c complex on the redox potential and pH were investigated using N,N,N",N"-tetramethyl-p-phenylenediamine (TMPD), ferrocyanide, and reduced 2,5-dimethyl-p-quinone as electron donors.	hexacyanoferrate II	205-217	cytochrome c, somatic	Homo sapiens	41-53
6284722-7	1982	Ferrocyanide reduced cytochrome c-555 slowly with a rate constant of 7.8 X 10(3) M-1.s-1 at infinite salt concentration.	hexacyanoferrate II	0-12	cytochrome c, somatic	Homo sapiens	21-33
6292175-5	1982	Addition of ferrocyanide to intact cytochrome c-depleted mitochondria does not reduce cytochrome c1; treatment with N,N,N",N"-tetramethylphenylenediamine, Triton X-100, or sonic oscillation results in 30% reduction of cytochromes c + c1.	hexacyanoferrate II	12-24	cytochrome c, somatic	Homo sapiens	35-47
6268746-1	1981	Use of rigorous equilibration kinetics to evaluate rate constants for the Fe(CN)6 4- reduction of horse-heart cytochrome c in the oxidized form, cyt c (III), has shown that limiting kinetics do not apply with concentrations of Fe(CN)6 4- (the reactant in excess) in the range 2-10 x 10(-4) M, I = 0.10 M (NaCl).	hexacyanoferrate II	74-83	cytochrome c, somatic	Equus caballus	110-122
6995116-1	1980	In the presence of hexacyanoferrate(III), or other suitable oxidants, transketolase catalyzes the oxidative cleavage of its donor substrates xylulose 5-phosphate or fructose 6-phosphate into glycolate and glyceraldehyde 3-phosphate or erythrose 4-phosphate, respectively.	hexacyanoferrate II	19-35	transketolase	Homo sapiens	70-83
227900-1	1979	The kinetics of the oxidation-reduction reactions between horse heart cytochrome c, Euglena gracilis cytochrome c552, and ions (ascorbate, ferricyanide, and ferrocyanide) was investigated as a function of ionic strength at pH 7, 25 degrees C. The ionic strength was varied between 0.002 and 0.02 M. Data were analyzed according to four different functions of ionic strength.	hexacyanoferrate II	157-169	cytochrome c, somatic	Equus caballus	70-82
195599-2	1977	Reduction of thermoresistant cytochrome c-552 and horse heart cytochrome c by ferrocyanide.	hexacyanoferrate II	78-90	cytochrome c, somatic	Equus caballus	29-41
7378421-1	1980	The alternative electron donors ferrocyanide and hydroquinone have been shown to also act as inhibitors of dopamine-beta-hydroxylase (3,4-dihydroxyphenylethylamine, ascorbate:oxygen oxidoreductase (beta-hydroxylating), EC 1.14.17.1).	hexacyanoferrate II	32-44	dopamine beta-hydroxylase	Homo sapiens	107-132
7378421-8	1980	The potency of inhibition of dopamine-beta-hydroxylase by both ferrocyanide and hydroquinone is dependent on the degree of protonation of a group in the enzyme having a pKa of 5.3.	hexacyanoferrate II	63-75	dopamine beta-hydroxylase	Homo sapiens	29-54
223635-3	1979	In the absence of cytochrome c, ferrocyanide or ferrous sulphate reduces cytochrome c oxidase (EC 1.9.3.1), but no continuous oxygen uptake ensues, as it does with N,N,N",N"-tetramethyl-p-phenylenediamine or reduced phenazine methosulphate as reductants, unless a substoichiometric amount of cytochrome c or an excess of clupein is present.	hexacyanoferrate II	32-44	cytochrome c, somatic	Homo sapiens	73-85
223635-3	1979	In the absence of cytochrome c, ferrocyanide or ferrous sulphate reduces cytochrome c oxidase (EC 1.9.3.1), but no continuous oxygen uptake ensues, as it does with N,N,N",N"-tetramethyl-p-phenylenediamine or reduced phenazine methosulphate as reductants, unless a substoichiometric amount of cytochrome c or an excess of clupein is present.	hexacyanoferrate II	32-44	cytochrome c, somatic	Homo sapiens	73-85
223635-6	1979	Cytochrome c, porphyrin cytochrome c and clupein all stimulate the reduction of cytochrome aa3 by ferrocyanide.	hexacyanoferrate II	98-110	cytochrome c, somatic	Homo sapiens	0-12
223635-6	1979	Cytochrome c, porphyrin cytochrome c and clupein all stimulate the reduction of cytochrome aa3 by ferrocyanide.	hexacyanoferrate II	98-110	cytochrome c, somatic	Homo sapiens	24-36
157102-0	1979	Novel pronounced reversible inhibition of phosphofructokinase, glucose 6-phosphate dehydrogenase, and phosphoglucose isomerase by hexacyanoferrate (II).	hexacyanoferrate II	130-146	glucose-6-phosphate dehydrogenase	Homo sapiens	63-96
157102-0	1979	Novel pronounced reversible inhibition of phosphofructokinase, glucose 6-phosphate dehydrogenase, and phosphoglucose isomerase by hexacyanoferrate (II).	hexacyanoferrate II	130-146	glucose-6-phosphate isomerase	Homo sapiens	102-126
447731-8	1979	An equimolar amount of cytochrome b5 was more effective than ferrocyanide in the enzymatic reduction of metmyoglobin.	hexacyanoferrate II	61-73	cytochrome b5 type A	Bos taurus	23-36
448060-0	1979	Ferrocyanide staining of transferrin and ferritin-conjugated antibody to transferrin.	hexacyanoferrate II	0-12	transferrin	Mus musculus	25-36
448060-0	1979	Ferrocyanide staining of transferrin and ferritin-conjugated antibody to transferrin.	hexacyanoferrate II	0-12	transferrin	Mus musculus	73-84
16660377-1	1978	The 4S cytochrome c (Cyt c) reductase activity of several plant species was markedly stimulated by cyanide and ferrocyanide but those of the 8S nitrate reductase component and other particulate components of the maize (Zea mays L.) scutellum by comparison, were increased only slightly.	hexacyanoferrate II	111-123	cytochrome c	Zea mays	7-19
16660377-1	1978	The 4S cytochrome c (Cyt c) reductase activity of several plant species was markedly stimulated by cyanide and ferrocyanide but those of the 8S nitrate reductase component and other particulate components of the maize (Zea mays L.) scutellum by comparison, were increased only slightly.	hexacyanoferrate II	111-123	cytochrome c	Zea mays	21-26
16660377-2	1978	The effect of cyanide and ferrocyanide was not due to elimination of cytochrome oxidase interference but resulted from the stimulation of NADH-dependent reduction of Cyt c.	hexacyanoferrate II	26-38	cytochrome c	Zea mays	166-171
16660377-3	1978	A 4S Cyt c reductase component which could be isolated by ammonium sulfate fractionation and diethyl-aminoethyl-cellulose chromatography was found to be stimulated markedly by cyanide and ferrocyanide.	hexacyanoferrate II	188-200	cytochrome c	Zea mays	5-10
195599-2	1977	Reduction of thermoresistant cytochrome c-552 and horse heart cytochrome c by ferrocyanide.	hexacyanoferrate II	78-90	cytochrome c, somatic	Equus caballus	62-74
32460478-6	2020	Among the investigated anions, the low-valent anions showed no impact on the ICR direction, while the high-valent component ferrocyanide [Fe(CN)64-] caused significant ICR inversion.	hexacyanoferrate II	124-136	general transcription factor IIE subunit 1	Homo sapiens	138-146
776982-0	1976	Oxidation of the carbanion intermediate of transaldolase by hexacyanoferrate (III).	hexacyanoferrate II	60-76	transaldolase 1	Homo sapiens	43-56
776982-1	1976	The transaldolase-dihydroxyacetone carbanion intermediate formed in the reaction of transaldolase with its donor substrates fructose-6-P or sedoheptulose-7-P is susceptible to oxidation by hexacyanoferrate(III).	hexacyanoferrate II	189-205	transaldolase 1	Homo sapiens	4-17
776982-1	1976	The transaldolase-dihydroxyacetone carbanion intermediate formed in the reaction of transaldolase with its donor substrates fructose-6-P or sedoheptulose-7-P is susceptible to oxidation by hexacyanoferrate(III).	hexacyanoferrate II	189-205	transaldolase 1	Homo sapiens	84-97
776982-4	1976	In the presence of hexacyanoferrate(III) transaldolase thus functions as an efficient catalyst of the oxidative cleavage of its donor substrates fructose-6-P or sedoheptulose-7-P into hydroxypyruvaldehyde and glyceraldehyde-3-P or erythrose-4-P, respectively.	hexacyanoferrate II	19-35	transaldolase 1	Homo sapiens	41-54
5116561-8	1971	The peroxide compound of yeast cytochrome c peroxidase was found to have two oxidizing equivalents accessible to cytochrome c but only one readily accessible to ferrocyanide.	hexacyanoferrate II	161-173	cytochrome-c peroxidase	Saccharomyces cerevisiae S288C	31-54
4172645-0	1967	A thiocholine-lead ferrocyanide method for acetylcholinesterase.	hexacyanoferrate II	19-31	acetylcholinesterase (Cartwright blood group)	Homo sapiens	43-63
33603152-4	2021	With use of an empirical rule of the frequencies of the CN- stretching mode in ferrocyanide ([FeII(CN)6]4-) and ferricyanide ([FeIII(CN)6]3-), the oxidation processes of Co-PBAs were determined against the Fe concentration (y) and temperature (T).	hexacyanoferrate II	79-91	general transcription factor IIE subunit 1	Homo sapiens	94-96
33151212-1	2020	Prebiotically plausible ferrocyanide-ferricyanide photoredox cycling oxidatively converts thiourea to cyanamide, whilst HCN is reductively homologated to intermediates which either react directly with the cyanamide giving 2-aminoazoles, or have the potential to do so upon loss of HCN from the system.	hexacyanoferrate II	24-36	metastasis associated lung adenocarcinoma transcript 1	Homo sapiens	120-123
33151212-1	2020	Prebiotically plausible ferrocyanide-ferricyanide photoredox cycling oxidatively converts thiourea to cyanamide, whilst HCN is reductively homologated to intermediates which either react directly with the cyanamide giving 2-aminoazoles, or have the potential to do so upon loss of HCN from the system.	hexacyanoferrate II	24-36	metastasis associated lung adenocarcinoma transcript 1	Homo sapiens	281-284
10021-9	1975	Ferrocyanide reduction of ferri-horse heart cytochrome c takes place in a kinetically complex manner.	hexacyanoferrate II	0-12	cytochrome c, somatic	Equus caballus	44-56
4368557-0	1974	Cytochrome c peroxidase catalyzed oxidation of ferrocyanide by hydrogen peroxide.	hexacyanoferrate II	47-59	cytochrome c, somatic	Homo sapiens	0-12
4368558-0	1974	Cytochrome c peroxidase catalyzed oxidation of ferrocyanide by hydrogen peroxide.	hexacyanoferrate II	47-59	cytochrome c, somatic	Homo sapiens	0-12
32545422-7	2020	The presence of fibrinogen caused only a negligible masking effect of the antioxidative abilities of resveratrol, measured by a reduction of hexacyanoferrate (III), while greatly increasing its solubility in an aqueous environment, thus increasing its potential bioavailability.	hexacyanoferrate II	141-157	fibrinogen beta chain	Homo sapiens	16-26
32215420-2	2020	Here, we report the use of hexacyanoferrate(ii) and hexacyanoferrate(iii) as electroactive crosslinking agents for the formation of nanometer-sized redox-active polyamine-redox-salt aggregates (rPSA) in bulk suspension.	hexacyanoferrate II	27-43	aminopeptidase puromycin sensitive	Rattus norvegicus	194-198
32215420-2	2020	Here, we report the use of hexacyanoferrate(ii) and hexacyanoferrate(iii) as electroactive crosslinking agents for the formation of nanometer-sized redox-active polyamine-redox-salt aggregates (rPSA) in bulk suspension.	hexacyanoferrate II	52-68	aminopeptidase puromycin sensitive	Rattus norvegicus	194-198
31713687-10	2019	Abeta(1-42) capturing by the peptide led to repulsion of ferrocyanide/ferricyanide redox couple.	hexacyanoferrate II	57-69	amyloid beta precursor protein	Homo sapiens	0-5
31864626-4	2020	The proposed protocols were conducted by using the model oxidoreductases of glucose oxidase (GOx) and the enzyme cascade of lactate dehydrogenase (LDH)/diaphorase to catalytically convert ferricyanide to ferrocyanide, which switched on fluorescence of the detection systems.	hexacyanoferrate II	204-216	hydroxyacid oxidase 1	Homo sapiens	76-91
31864626-4	2020	The proposed protocols were conducted by using the model oxidoreductases of glucose oxidase (GOx) and the enzyme cascade of lactate dehydrogenase (LDH)/diaphorase to catalytically convert ferricyanide to ferrocyanide, which switched on fluorescence of the detection systems.	hexacyanoferrate II	204-216	hydroxyacid oxidase 1	Homo sapiens	93-96
30831419-5	2019	The interaction of the CRH with the recognition layer of the immobilized half-antibody on the nanostructured surface was carried out by incubation at 4  C for 2 h. A dissolution of [Fe(CN)6]4-/[Fe(CN)6]3- as a redox probe was used to study the electrochemical responses of the nanostructured surface and the immobilization processes of the half-antibody and detection of CRH, using cyclic voltammetry and electrochemical impedance spectroscopy.	hexacyanoferrate II	182-191	corticotropin releasing hormone	Homo sapiens	23-26
31243577-5	2019	If the CRP on the paper device is contacted with Ca (II) ions, the current (measured by using hexacyanoferrate as the electrochemical probe) decreases.	hexacyanoferrate II	94-110	C-reactive protein	Homo sapiens	7-10
31243577-5	2019	If the CRP on the paper device is contacted with Ca (II) ions, the current (measured by using hexacyanoferrate as the electrochemical probe) decreases.	hexacyanoferrate II	94-110	carbonic anhydrase 2	Homo sapiens	49-56
23999654-3	2013	In this investigation the Donnan potential of PEI-(PGA-PAH)n (PEI, PGA and PAH stand for polyethyleneimine, poly-L-glutamic acid and polyallylamine) films will be determined as a function of the number of deposition steps and the concentration of the redox probe, hexacyanoferrate anions, for films made from 10 layer pairs.	hexacyanoferrate II	264-280	phenylalanine hydroxylase	Homo sapiens	55-58
30732787-5	2019	Co(II)-chelated CEC cryogels have been used for fabrication of Co(II) ferrocyanide-containing composite with the distribution coefficient for 137Cs of 140,000 ml/g and the adsorption capacity of ~1 mmol/g.	hexacyanoferrate II	70-82	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	0-5
30732787-5	2019	Co(II)-chelated CEC cryogels have been used for fabrication of Co(II) ferrocyanide-containing composite with the distribution coefficient for 137Cs of 140,000 ml/g and the adsorption capacity of ~1 mmol/g.	hexacyanoferrate II	70-82	mitochondrially encoded cytochrome c oxidase II	Homo sapiens	0-6
30712159-6	2019	CRP was quantified by measuring the changes in the charge-transfer resistance of the electrode by using hexacyanoferrate as the redox probe.	hexacyanoferrate II	104-120	C-reactive protein	Homo sapiens	0-3
29594452-7	2018	Hexacyanoferrate was used as an electrochemical probe to study the dependence of the peak current on lysozyme concentration.	hexacyanoferrate II	0-16	lysozyme	Homo sapiens	101-109
29594452-14	2018	The changes of peak current for the electrochemical probe hexacyanoferrate (Fe(CN)63-/4-) in the presence and absence of lysozyme was traced.	hexacyanoferrate II	58-74	lysozyme	Homo sapiens	121-129
29594654-0	2018	Aptamer-based determination of tumor necrosis factor alpha using a screen-printed graphite electrode modified with gold hexacyanoferrate.	hexacyanoferrate II	120-136	tumor necrosis factor	Homo sapiens	31-58
27973360-2	2016	This paper deals with the degradation of acid red-26 (AR-26), an azo dye by hexacyanoferrate (abbreviated as HCF) (III) using iridium nanoparticles.	hexacyanoferrate II	76-92	host cell factor C1	Homo sapiens	109-112
26588324-6	2015	The specific interaction of CRP with phosphorylcholine in a calcium-containing buffer solution was determined by differential pulse voltammetry, which measures the altered redox reaction between the indicators ferricyanide/ferrocyanide as a result of the binding event.	hexacyanoferrate II	223-235	C-reactive protein	Homo sapiens	28-31
26343443-1	2015	We present a novel electrochemical glucose sensor employing an interdigitated array (IDA) of 1:1 aspect ratio carbon nanoelectrodes for the electrochemical-enzymatic redox cycling of redox species (ferricyanide/ferrocyanide) between glucose oxidase (GOx) and the two comb-shaped nanoelectrodes of the IDA.	hexacyanoferrate II	211-223	hydroxyacid oxidase 1	Homo sapiens	233-248
26343443-1	2015	We present a novel electrochemical glucose sensor employing an interdigitated array (IDA) of 1:1 aspect ratio carbon nanoelectrodes for the electrochemical-enzymatic redox cycling of redox species (ferricyanide/ferrocyanide) between glucose oxidase (GOx) and the two comb-shaped nanoelectrodes of the IDA.	hexacyanoferrate II	211-223	hydroxyacid oxidase 1	Homo sapiens	250-253
25127647-6	2014	At a higher menadione concentration (100 muM), the ferrocyanide generation rate decreased within 30 min because of the cytotoxic effect of menadione.	hexacyanoferrate II	51-63	latexin	Homo sapiens	41-44
30431259-7	2018	Finally, we show that the exposed interface between sp2 and sp3 carbon layers (i.e. the laser-ablated diamond surface) revealed faster kinetics than the untreated BDD in both ferrocyanide and RuHex mediators, which can be used for electrochemical (bio)sensing.	hexacyanoferrate II	175-187	Sp2 transcription factor	Homo sapiens	52-55
30431259-7	2018	Finally, we show that the exposed interface between sp2 and sp3 carbon layers (i.e. the laser-ablated diamond surface) revealed faster kinetics than the untreated BDD in both ferrocyanide and RuHex mediators, which can be used for electrochemical (bio)sensing.	hexacyanoferrate II	175-187	Sp3 transcription factor	Homo sapiens	60-63
30101890-7	2018	Thus, epsilonPL is considered to be a useful additive for glucose sensors based on the [Fe(CN)6]4-/3--mediated GOx catalytic current.	hexacyanoferrate II	88-97	hydroxyacid oxidase 1	Homo sapiens	111-114
29018930-4	2017	Under the optimal experimental conditions, the DPV peak currents of hexacyanoferrate/hexacyanoferrite changed linearly with Gly concentration in the range from 5 to 800 ng mL-1, with a detection limit of 0.27 ng mL-1 (S/N = 3).	hexacyanoferrate II	68-84	L1 cell adhesion molecule	Mus musculus	172-176
29018930-4	2017	Under the optimal experimental conditions, the DPV peak currents of hexacyanoferrate/hexacyanoferrite changed linearly with Gly concentration in the range from 5 to 800 ng mL-1, with a detection limit of 0.27 ng mL-1 (S/N = 3).	hexacyanoferrate II	68-84	L1 cell adhesion molecule	Mus musculus	212-216
28671628-3	2017	In addition, the effect of the ferrocyanide concentration on the SWASV detection of Cd2+ in the presence of Cu2+ was investigated.	hexacyanoferrate II	31-43	CD2 molecule	Homo sapiens	84-87
27607732-2	2016	Herein we demonstrate for the first time the liberation of CH4 and NH3 from a well-defined iron cyanide coordination complex, [SiP(iPr) 3 ]Fe(CN) (where [SiP(iPr) 3 ] represents a tris(phosphine)silyl ligand), on exposure to proton and electron equivalents.	hexacyanoferrate II	91-103	tumor protein p53 inducible nuclear protein 1	Homo sapiens	127-137
27607732-2	2016	Herein we demonstrate for the first time the liberation of CH4 and NH3 from a well-defined iron cyanide coordination complex, [SiP(iPr) 3 ]Fe(CN) (where [SiP(iPr) 3 ] represents a tris(phosphine)silyl ligand), on exposure to proton and electron equivalents.	hexacyanoferrate II	91-103	tumor protein p53 inducible nuclear protein 1	Homo sapiens	154-164
25127647-4	2014	Generation of ferrocyanide was observed immediately after the addition of a lower concentration (10 muM) of menadione.	hexacyanoferrate II	14-26	latexin	Homo sapiens	100-103
24296061-2	2014	The biotinylated aptamer of thrombin was immobilized onto an avidin-graphite epoxy composite (AvGEC) electrode surface by affinity interaction between biotin and avidin; electrochemical impedance measurements were performed in a solution containing the redox marker ferrocyanide/ferricyanide.	hexacyanoferrate II	266-278	coagulation factor II, thrombin	Homo sapiens	28-36
24437480-3	2014	Cyclic voltammetry displays a reversible peak with E(1/2) at -1.04 V vs ferrocyanide attributed to the (Co(III/II)TCPP)CoPIZA redox couple and a quasi-reversible peak at -1.45 V vs ferrocyanide, which corresponds to the reduction of (Co(II/I)TCPP)CoPIZA.	hexacyanoferrate II	72-84	mitochondrially encoded cytochrome c oxidase III	Homo sapiens	107-110
23999654-3	2013	In this investigation the Donnan potential of PEI-(PGA-PAH)n (PEI, PGA and PAH stand for polyethyleneimine, poly-L-glutamic acid and polyallylamine) films will be determined as a function of the number of deposition steps and the concentration of the redox probe, hexacyanoferrate anions, for films made from 10 layer pairs.	hexacyanoferrate II	264-280	phenylalanine hydroxylase	Homo sapiens	75-78
22294389-4	2012	CDH induces PB formation via both reduction of ferricyanide to ferrocyanide reacting with an excess of Fe3+ (pathway 1) and reduction of ferric ions to Fe2+ reacting with the excess of ferricyanide (pathway 2).	hexacyanoferrate II	63-75	choline dehydrogenase	Homo sapiens	0-3
23780697-3	2013	However, in the presence of iron, the HCN was captured in the form of a ferrocyanide, partially inhibiting the formation of amino acids.	hexacyanoferrate II	72-84	metastasis associated lung adenocarcinoma transcript 1	Homo sapiens	38-41
22101009-8	2012	A simple kinetic model of NO autoxidation is able to explain the extent of cytochrome c oxidation assuming a rate constant of 3x10(6)M(-1)s(-1) for the reaction of NO(2)( ) with ferrocytochrome c. The importance of NO(2)( ) was confirmed by the addition of scavengers such as urate and ferrocyanide.	hexacyanoferrate II	286-298	cytochrome c, somatic	Homo sapiens	75-87
22177076-4	2012	In electrochemical biosensors, interactions between the immobilized kappa-CN molecules and chymosin (the active component of rennet) were studied by performing cyclic voltammetry, differential pulsed voltammetry, and electrochemical impedance spectroscopy (EIS) measurements, using hexacyanoferrate(II)/(III) couple as a redox probe.	hexacyanoferrate II	282-298	casein kappa	Homo sapiens	68-76
22666416-5	2012	Based on ferrocyanide quenching, fluorescence polarization, quantum yield values and viscosity results a strong intercalative binding of BC1 and BC2 to the RNA triplex has been demonstrated.	hexacyanoferrate II	9-21	charged multivesicular body protein 2A	Homo sapiens	145-148
22132924-10	2011	The CSF flow pathway was traced by staining the ferritin with ferrocyanide.	hexacyanoferrate II	62-74	colony stimulating factor 2	Rattus norvegicus	4-7
17205271-4	2007	Electrochemical impedance spectroscopy (EIS) of ferrocyanide followed the assembly process and verified the successful immobilization of IO(4)(-) - GOx on ASNPs modified on gold electrodes.	hexacyanoferrate II	48-60	hydroxyacid oxidase 1	Homo sapiens	148-151
21073422-0	2010	Inhibition of transketolase by hexacyanoferrate(III).	hexacyanoferrate II	31-47	transketolase	Homo sapiens	14-27
21073422-1	2010	The effect of hexacyanoferrate(III) on the catalytic activity of transketolase has been studied.	hexacyanoferrate II	14-30	transketolase	Homo sapiens	65-78
19456182-4	2009	In neutral electrolytes, the LS1- and LS2-modified electrodes behaved as anionic coatings, showing an increase in the charge transfer resistance (R(ct)) for the ferrocyanide/ferricyanide redox couple.	hexacyanoferrate II	161-173	serpin family D member 1	Homo sapiens	38-41
19123805-5	2009	Films constituted by more than nine PSS/PAH bilayers are still permeable to hexacyanoferrate(II) ions, Fe(CN)(6)4-, whatever the nature of the supporting salt anion.	hexacyanoferrate II	76-92	PSS	Homo sapiens	36-39
19123805-5	2009	Films constituted by more than nine PSS/PAH bilayers are still permeable to hexacyanoferrate(II) ions, Fe(CN)(6)4-, whatever the nature of the supporting salt anion.	hexacyanoferrate II	76-92	phenylalanine hydroxylase	Homo sapiens	40-43
18755579-7	2008	Binding of thrombin to an aptamer has also been detected using the ferricyanide/ferrocyanide redox couple as electrochemical indicator.	hexacyanoferrate II	80-92	coagulation factor II, thrombin	Homo sapiens	11-19
17203264-4	2007	NADH is converted to NAD+ by applying hexacyanoferrate(III) as oxidant in the presence of DI.	hexacyanoferrate II	38-54	dihydrolipoamide dehydrogenase	Homo sapiens	90-92
21035664-4	2010	In addition, the electrocatalytic behavior of this modified electrode was exploited as a sensitive detection system for the reduction of RDX high explosive, hydrogen peroxide and hexacyanoferrate (HCF) by cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques.	hexacyanoferrate II	197-200	radixin	Homo sapiens	137-140
16618178-3	2006	Approach curves were recorded with ferrocyanide as a mediator at different coverages of cytochrome c and at different substrate potentials, allowing the measurement of k(BI) = 2 x 10(8) mol(-1) cm3 s(-1) for the bimolecular ET and k degrees = 15 s(-1) for the tunneling ET.	hexacyanoferrate II	35-47	cytochrome c, somatic	Homo sapiens	88-100
15780631-8	2005	The best hCA IV inhibitors were dicyanocuprate (K(I) of 9.8 microM) and hexacyanoferrate(II) (K(I) of 10.0 microM), whereas the worst ones were tetrafluoroborate and hexafluoroaluminate (K(I)s in the range of 124-126 mM).	hexacyanoferrate II	72-88	carbonic anhydrase 4	Homo sapiens	9-15
16018892-1	2005	Upon exposure to ultraviolet (UV) radiation, non-toxic hexacyanoferrate (II) (Fe(CN)6(-4)) undergoes direct photolysis, resulting in the liberation of toxic free cyanide (HCN,CN-).	hexacyanoferrate II	55-71	metastasis associated lung adenocarcinoma transcript 1	Homo sapiens	171-174
15807618-3	2005	However, the contact of this film with a poly(allylamine) (PAH) or a poly(L-glutamic acid) (PGA) solution leads to the release of ferrocyanide ions from the multilayer.	hexacyanoferrate II	130-142	phenylalanine hydroxylase	Homo sapiens	59-62
15807618-6	2005	When the film is then brought in contact with a PAH solution, the PAH chains from the solution are expected to strongly interact with the ferrocyanide ions and thus induce a diffusion mechanism of the multivalent anions out of the film, the film/solution interface playing the role of a sink for these ions.	hexacyanoferrate II	138-150	phenylalanine hydroxylase	Homo sapiens	48-51
15807618-6	2005	When the film is then brought in contact with a PAH solution, the PAH chains from the solution are expected to strongly interact with the ferrocyanide ions and thus induce a diffusion mechanism of the multivalent anions out of the film, the film/solution interface playing the role of a sink for these ions.	hexacyanoferrate II	138-150	phenylalanine hydroxylase	Homo sapiens	66-69
15780631-10	2005	The best hCA IX inhibitors were on the other hand cyanide, heptafluoroniobate and dicyanoargentate (K(I)s in the range of 4 microM-0.33 mM), whereas the worst ones were hexacyanoferrate(III) and hexacyanoferrate(II).	hexacyanoferrate II	169-185	carbonic anhydrase 9	Homo sapiens	9-15
15780631-10	2005	The best hCA IX inhibitors were on the other hand cyanide, heptafluoroniobate and dicyanoargentate (K(I)s in the range of 4 microM-0.33 mM), whereas the worst ones were hexacyanoferrate(III) and hexacyanoferrate(II).	hexacyanoferrate II	195-211	carbonic anhydrase 9	Homo sapiens	9-15
14999009-7	2004	The addition of ferrocyanide enhanced both the reduction rate and final reduction level of the diethylpyrocarbonate-treated cytochrome b(561) when ascorbate was used as a reductant.	hexacyanoferrate II	16-28	cytochrome b	Bos taurus	124-136
15449937-0	2004	Crystal structures of HbA2 and HbE and modeling of hemoglobin delta 4: interpretation of the thermal stability and the antisickling effect of HbA2 and identification of the ferrocyanide binding site in Hb.	hexacyanoferrate II	173-185	hemoglobin subunit alpha 2	Homo sapiens	22-26
15449937-11	2004	The crystal structure of a ferrocyanide-bound HbA(2) at 1.88 A resolution is also presented here, which throws light on the location and the mode of binding of ferrocyanide anion with hemoglobin, predominantly using the residues involved in DPG binding.	hexacyanoferrate II	27-39	hemoglobin subunit alpha 2	Homo sapiens	46-52
11570891-3	2001	Ferri/ferrocyanide can mediate reduction of DEPC-treated cytochrome b(561) by ascorbic acid, indicating that DEPC-inhibited cytochrome b(561) cannot accept electrons from a hydrogen-atom donor like ascorbate but can still accept electrons from an electron donor like ferrocyanide.	hexacyanoferrate II	6-18	mitochondrially encoded cytochrome b	Homo sapiens	57-69
12379149-7	2003	The anion-activated DBH was inhibited when assayed with ferrocyanide and activated when assayed with TMPD as electron donors by increasing the pH (5.1 to 6.0).	hexacyanoferrate II	56-68	dopamine beta-hydroxylase	Homo sapiens	20-23
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	112-128	ferritin heavy chain 1	Homo sapiens	20-31
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	112-128	ferritin heavy chain 1	Homo sapiens	210-221
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	169-185	ferritin heavy chain 1	Homo sapiens	20-31
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	169-185	ferritin heavy chain 1	Homo sapiens	210-221
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	169-185	ferritin heavy chain 1	Homo sapiens	20-31
14577762-1	2003	The dissociation of apoferritin into subunits at pH 2 followed by its re-formation at pH 8.5 in the presence of hexacyanoferrate(III) gave rise to a solution containing hexacyanoferrate(III) trapped within the apoferritin and hexacyanoferrate(III) outside it.	hexacyanoferrate II	169-185	ferritin heavy chain 1	Homo sapiens	210-221
16220934-1	2003	We developed a simple contrasting procedure to improve the AFM visualization of single positively charged polymer chains deposited on substrates of a relatively high roughness via the decoration of the molecules with hexacyanoferrate anions or negatively charged clusters of cyanide-bridged complexes.	hexacyanoferrate II	217-233	afamin	Homo sapiens	59-62
11570891-3	2001	Ferri/ferrocyanide can mediate reduction of DEPC-treated cytochrome b(561) by ascorbic acid, indicating that DEPC-inhibited cytochrome b(561) cannot accept electrons from a hydrogen-atom donor like ascorbate but can still accept electrons from an electron donor like ferrocyanide.	hexacyanoferrate II	6-18	mitochondrially encoded cytochrome b	Homo sapiens	124-136
11421701-1	2001	Radical salts of bis(ethylenethia)tetrathiafulvalene (BET-TTF) with the octahedral anions hexacyanoferrate(III) and nitroprusside.	hexacyanoferrate II	90-106	delta/notch like EGF repeat containing	Homo sapiens	54-57
11569835-1	2001	Limiting currents for the reduction of hexacyanoferrate-(III), i(lim), in aqueous solutions have been recorded in the presence of convective flow generated by a focused acoustic source with its main axis placed normal to the surface of a circular Au electrode embedded in a coplanar Teflon shroud.	hexacyanoferrate II	39-55	PDZ and LIM domain 5	Homo sapiens	65-68
11421701-1	2001	Radical salts of bis(ethylenethia)tetrathiafulvalene (BET-TTF) with the octahedral anions hexacyanoferrate(III) and nitroprusside.	hexacyanoferrate II	90-106	ras homolog family member H	Homo sapiens	58-61
10502069-1	1999	We describe an improved copper ferrocyanide-based method for cytochemical detection of glucose-6-phosphate dehydrogenase (G6PD), which was used to localize the enzyme within the ultrastructure of rat hepatocytes and adrenocortical cells.	hexacyanoferrate II	31-43	glucose-6-phosphate dehydrogenase	Rattus norvegicus	87-120
10834943-3	2000	In the present study, ferrocyanide and thiols, which are susceptible to one-electron and two-electron oxidation, respectively, were subjected to a flux of superoxide in the presence and absence of SOD or SOD mimics.	hexacyanoferrate II	22-34	superoxide dismutase 1	Homo sapiens	197-200
23604878-1	2001	The ultrastructural features of perikaryal mitochondria positive to the copper ferrocyanide cytochemical reaction due to SDH activity were investigated in Purkinje cells of adult rats fed a vitamin E (alpha-tocopherol) deficient diet (AVED) for 11 months.	hexacyanoferrate II	79-91	serine dehydratase	Rattus norvegicus	121-124
11005823-1	2000	The copper- and zinc-containing superoxide dismutase can catalyze the oxidation of ferrocyanide by O(2) as well as the reduction of ferricyanide by O(2).	hexacyanoferrate II	83-95	superoxide dismutase 1	Homo sapiens	32-52
10502069-1	1999	We describe an improved copper ferrocyanide-based method for cytochemical detection of glucose-6-phosphate dehydrogenase (G6PD), which was used to localize the enzyme within the ultrastructure of rat hepatocytes and adrenocortical cells.	hexacyanoferrate II	31-43	glucose-6-phosphate dehydrogenase	Rattus norvegicus	122-126
1846158-4	1991	On the basis of oxidative polymerization of 3, 3"-diaminobenzidine by cytochrome oxidase (CYO) an cupric ferrocyanide deposition by monoamine oxidase (MAO), microcylinders were demonstrated to exhibit activity of these enzymes.	hexacyanoferrate II	105-117	monoamine oxidase A	Rattus norvegicus	132-149
9526032-0	1998	Ferrocyanide-peroxidase activity of cytochrome c oxidase Redox interaction of mitochondrial cytochrome c oxidase (COX) with ferrocyanide/ferricyanide couple is greatly accelerated by polycations, such as poly-l-lysine [Musatov et al.	hexacyanoferrate II	124-136	cytochrome c, somatic	Homo sapiens	36-48
9526032-0	1998	Ferrocyanide-peroxidase activity of cytochrome c oxidase Redox interaction of mitochondrial cytochrome c oxidase (COX) with ferrocyanide/ferricyanide couple is greatly accelerated by polycations, such as poly-l-lysine [Musatov et al.	hexacyanoferrate II	124-136	cytochrome c, somatic	Homo sapiens	92-104
8286338-9	1994	The fluorescence decrease with time paralleled the decrease in activity of H2O2-oxidized CCP using both ferrocytochrome c and ferrocyanide as substrates, indicating that tryptophan and activity loss occurred on similar time scales.	hexacyanoferrate II	126-138	cytochrome-c peroxidase	Saccharomyces cerevisiae S288C	89-92
1552180-1	1992	We introduce a one-step histochemical method with cobalt as the precipitating agent for ferrocyanide for the light microscopic demonstration of acetylcholinesterase activity.	hexacyanoferrate II	88-100	acetylcholinesterase (Cartwright blood group)	Homo sapiens	144-164
18967368-3	1998	Some considerations regarding the current signals obtained from flow injection experiments using both a 5- and a 750-mum radius platinum electrode were carried out in order to achieve the lowest limit of detection, a value of 0.03 mumol dm(-3) ferrocyanide being calculated by using the 5-mum radius microelectrode as amperometric detector.	hexacyanoferrate II	244-256	latexin	Homo sapiens	117-120
18967368-3	1998	Some considerations regarding the current signals obtained from flow injection experiments using both a 5- and a 750-mum radius platinum electrode were carried out in order to achieve the lowest limit of detection, a value of 0.03 mumol dm(-3) ferrocyanide being calculated by using the 5-mum radius microelectrode as amperometric detector.	hexacyanoferrate II	244-256	latexin	Homo sapiens	231-234
1846158-4	1991	On the basis of oxidative polymerization of 3, 3"-diaminobenzidine by cytochrome oxidase (CYO) an cupric ferrocyanide deposition by monoamine oxidase (MAO), microcylinders were demonstrated to exhibit activity of these enzymes.	hexacyanoferrate II	105-117	monoamine oxidase A	Rattus norvegicus	151-154
2155024-8	1990	Acta 784, 189-191) reductants such as ascorbic acid and ferrocyanide convert Compound II, which accumulates during turnover, into active myeloperoxidase.	hexacyanoferrate II	56-68	myeloperoxidase	Homo sapiens	137-152
33773728-3	2021	Firstly, ascorbic acid, a product from ALP-catalyzed hydrolysis of 2-phospho-l-ascorbic acid (AAP), converted yellow ferricyanide into ferrocyanide.	hexacyanoferrate II	135-147	alkaline phosphatase, placental	Homo sapiens	39-42
33773728-3	2021	Firstly, ascorbic acid, a product from ALP-catalyzed hydrolysis of 2-phospho-l-ascorbic acid (AAP), converted yellow ferricyanide into ferrocyanide.	hexacyanoferrate II	135-147	serpin family F member 2	Homo sapiens	94-97
34534004-6	2021	The adsorption of ferrocyanide onto kaolinite indicates an exothermic and outer-sphere interaction, which results in degeneracy breakdown for C   N stretch energy into two new bands of FTIR-ATR spectrum.	hexacyanoferrate II	18-30	ATR serine/threonine kinase	Homo sapiens	190-193
34361764-0	2021	Composite Zn(II) Ferrocyanide/Polyethylenimine Cryogels for Point-of-Use Selective Removal of Cs-137 Radionuclides.	hexacyanoferrate II	17-29	citrate synthase	Homo sapiens	94-96
34764826-6	2021	In ferrocyanide medium, PSA detection as low as 3, 2.96, and 0.85 ng mL-1 was achieved with a dynamic range from 0.5 to 7 ng ml-1, in accord with clinical values, using cyclic voltammetry, square wave voltammetry, and electrochemical impedance spectroscopy, respectively.	hexacyanoferrate II	3-15	kallikrein related peptidase 3	Homo sapiens	24-27